The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children

The New England Journal of Medicine
F Y LinS C Szu

Abstract

Typhoid fever is common in developing countries. The licensed typhoid vaccines confer only about 70 percent immunity, do not protect young children, and are not used for routine vaccination. A newly devised conjugate of the capsular polysaccharide of Salmonella typhi, Vi, bound to nontoxic recombinant Pseudomonas aeruginosa exotoxin A (rEPA), has enhanced immunogenicity in adults and in children 5 to 14 years old and has elicited a booster response in children 2 to 4 years old. In a double-blind, randomized trial, we evaluated the safety, immunogenicity, and efficacy of the Vi-rEPA vaccine in children two to five years old in 16 communes in Dong Thap Province, Vietnam. Each of the 11,091 children received two injections six weeks apart of either Vi-rEPA or a saline placebo. Cases of typhoid, diagnosed by the isolation of S. typhi from blood cultures after 3 or more days of fever (a temperature of 37.5 degrees C or higher), were identified by active surveillance over a period of 27 months. We estimated efficacy by comparing the attack rate of typhoid in the vaccine group with that in the placebo group. S. typhi was isolated from 4 of the 5525 children who were fully vaccinated with Vi-rEPA and from 47 of the 5566 children who re...Continue Reading

References

Oct 26, 1991·Lancet·C H SimanjuntakS L Hoffman
Sep 1, 1991·Reviews of Infectious Diseases·Z A BhuttaB J Farooqui
Aug 1, 1987·American Journal of Diseases of Children·U ThisyakornD N Taylor
Apr 1, 1985·Statistics in Medicine·O Miettinen, M Nurminen
Feb 1, 1969·Archives of Disease in Childhood·J ScraggH L Wallace
Feb 1, 1966·Archives of Disease in Childhood·H GallowayM Blackhall
Sep 1, 1984·The Journal of Infectious Diseases·J D Robbins, J B Robbins
May 1, 1980·Journal of Medical Microbiology·C M NolanJ B Robbins
Feb 7, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J WainC M Parry
Sep 4, 1999·Lancet·A SinhaM K Bhan
Jul 1, 1959·Indian Journal of Pediatrics·P T RAO, K V RAO

❮ Previous
Next ❯

Citations

Jul 17, 2003·Current Gastroenterology Reports·Nancy F Crum
Jan 22, 2004·Current Infectious Disease Reports·Christopher M. Parry
Feb 26, 2009·Current Infectious Disease Reports·Laila Woc-Colburn, David A Bobak
May 2, 2009·Archives of Pharmacal Research·Kyungdong BaeByungki Hur
Mar 18, 2004·Biologicals : Journal of the International Association of Biological Standardization·Sjoerd RijpkemaChristopher Jones
Apr 20, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Morad HassaniLiise-Anne Pirofski
Oct 15, 2013·The Journal of Infection·Claire S WaddingtonAndrew J Pollard
Aug 16, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·H H TranP J Guerin
Apr 12, 2002·The Lancet Infectious Diseases·John WainGordon Dougan
Apr 2, 2010·Nature Reviews. Drug Discovery·Rena D Astronomo, Dennis R Burton
Apr 26, 2001·The New England Journal of Medicine·R L Guerrant, M Kosek
Aug 25, 2001·The New England Journal of Medicine·P A Koul
Oct 3, 2003·The New England Journal of Medicine·Ngoc Lanh MaiShousun C Szu
Oct 6, 2001·The New England Journal of Medicine·G Ada
Nov 29, 2002·The New England Journal of Medicine·Christopher M ParryJeremy J Farrar
Jun 19, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Quoc Chanh NguyenJohn Wain
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E B SteinbergE D Mintz
Jul 14, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R Leon OchiaiJohn D Clemens
Dec 18, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John A Crump, Eric D Mintz
Jul 19, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David SkurnikGerald B Pier
Aug 18, 2012·The Journal of Antimicrobial Chemotherapy·Damien RouxDavid Skurnik
Aug 13, 2003·The Pediatric Infectious Disease Journal·Justen H PasswellUNKNOWN Israel Shigella Study Group
Nov 4, 2010·The Pediatric Infectious Disease Journal·Aatekah OwaisAnita K M Zaidi
Jul 19, 2006·Clinical Microbiology Reviews·David J Diemert
Oct 5, 2001·Clinical Microbiology Reviews·P H Dennehy
Jun 2, 2011·Infection and Immunity·Janet C LindowBeth D Kirkpatrick
Jan 24, 2006·Infection and Immunity·Mark L Lang, Aharona Glatman-Freedman
Mar 7, 2002·Journal of Clinical Microbiology·Geeta Mehta, Subhash C Arya
Mar 8, 2005·Journal of Clinical Microbiology·John WainRumina Hasan
Apr 3, 2008·The Journal of Clinical Investigation·William A PetriRichard L Guerrant

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.